Retail sale of pharmaceutical products
VEAKROSSEN APOTEK AS
Revenue 2024
NOK 19.8m
Operating profit
NOK 1.0m
Equity
NOK 1.1m
Incorporated
2022
Employees
9
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 19.8m | |
| Total operating costs | 18.7m | |
| Operating profit (EBIT) | 1.0m | |
| Net financial items | 64k | |
| Profit for the year | 861k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 18.1m | |
| of which current assets | 16.9m | |
| Equity | 1.1m | |
| Total liabilities | 17.0m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.